Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifuratel and nystatin vaginal soft capsules for bacterial vaginosis
CTR20232737Phase 3Completed
- Sponsor
- Yantai Luyin Pharmaceutical
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifuratel + nystatin in bacterial vaginosis (BV), sponsored by Yantai Luyin Pharmaceutical. Started Sep 2023; status: completed.
02
Drugs
nifuratel + nystatin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20232737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232737.